facebook pixel Skip to main content

Case Study: Isabella, 17-Year-Old Female with PCOS, Anxiety, and Depression

While all case studies are based on actual patients, significant aspects of the case have been changed to conceal the patient’s original identity.

Initial Presentation

Patient Demographics

  • Name: Isabella (Name changed for privacy)
  • Age: 17
  • Ethnicity: Latina
  • Location: New York City
  • School: Enrolled in a magnet program with a demanding academic workload

Chief Complaints

  • Mood instability: Irritability, anger, and emotional variability, especially with parents
  • Sleep disruption: Poor sleep quality, averaging 4-5 hours per night
  • Fatigue: Low energy overall, highest in the morning, dips in the afternoon, and surges late at night
  • Headaches: 2-4 times per week
  • Menstrual health: Polycystic ovarian syndrome (PCOS); currently taking birth control pills (BCP)

Relevant Medical & Family History

  • No history of self-harm or suicidal ideation
  • Family history of depression and metabolic disorders
  • No previous psychiatric hospitalizations

Clinical Assessment:

Diagnosis

  1. Polycystic Ovarian Syndrome (PCOS)
  2. Generalized Anxiety Disorder (GAD) and Depression
  3. Cortisol Dysregulation and Adrenal Fatigue

Objective Findings

  • Laboratory Testing:
    • Elevated androgens (suggestive of PCOS-related hormonal imbalance)
    • Mild insulin resistance (elevated fasting insulin)
    • Elevated evening cortisol
    • Low vitamin D, magnesium, and B12
    • Mildly elevated C-reactive protein (CRP), indicating inflammation
  • Behavioral and Psychological Observations:
    • Appears withdrawn and fatigued during consultation
    • Expresses feelings of being overwhelmed by school workload

Intervention and Treatment Plan for PCOS, Anxiety, and Depression:

1. Lifestyle and Sleep Hygiene

  • Establish consistent bedtime routine
  • Reduce light exposure 1 hour before bed
  • Magnesium Glycinate (200 mg) before bed to improve relaxation and sleep quality
  • Daily mindfulness/meditation (5 minutes) to reduce stress and anxiety

2. Nutritional Support & Supplementation

  • Dietary Adjustments:
    • Increase protein and healthy fats at each meal
    • Reduce refined sugar and processed carbohydrates
    • Increase anti-inflammatory foods (e.g., turmeric, leafy greens, omega-3s)
  • Supplements:
    • Vitamin D3 (2,000 IU daily) – Supports immune function and mood (Holick, 2011)
    • Magnesium Glycinate (200 mg twice daily) – Improves sleep and relaxation (Boyle et al., 2017)
    • Inositol (4 g daily) – Supports insulin sensitivity and hormone regulation in PCOS (Unfer et al., 2017)
    • B Complex (with methylfolate and B12) – Supports neurotransmitter function and energy (Young, 2007)

3. Botanical & Nutraceutical Interventions:

  • SAMe (200-800 mg daily): Methyl donor that reduces depressive symptoms (Papakostas, 2010)
  • Adrenal Glandular (morning and early afternoon): Supports adrenal function (Wilson, 2014)
  • Magnolia (evening): Reduces stress perception and cortisol exposure (Talbott et al., 2013)
  • Ashwagandha (evening): Adaptogen that reduces stress and anxiety (Chandrasekhar et al., 2012)
  • Melatonin 1.2 mg (slow release, before bed): Supports circadian rhythm and sleep regulation (Ferracioli-Oda et al., 2013)
  • L-Tyrosine (morning): Enhances alertness, mental performance, and memory (Neri et al., 1995)
  • Curcumin (morning and evening): Reduces inflammation and supports mood (Lopresti et al., 2014)
  • 5-HTP (evening): Increases serotonin levels and supports mood stability (Birdsall, 1998)

Progress Evaluation:

October Follow-up (4 Weeks Post-Treatment Initiation)

  • Mood: Less irritable and sad, though some fluctuations remain
  • Energy: Improving, especially in the morning and early afternoon
  • Sleep: Increased to 5-6 hours per night
  • Headaches: Reduced to 1 per week

January Follow-up (3 Months Post-Treatment Initiation)

  • Mood: Parents report that they “feel like their daughter is back”; Isabella reports no sadness
  • Energy: Increased and stable throughout the day
  • Sleep: Improved to 7-8 hours per night
  • Headaches: Reduced to 1-2 per month
  • Emotional Stability: More joyful, engaged, and motivated

Follow-up Lab Testing (January)

  • CRP (Inflammation Marker): Lowered, indicating reduced systemic inflammation
  • Fasting Insulin Levels: Improved, suggesting better metabolic control
  • Evening Cortisol Levels: More balanced, reflecting better stress management

Conclusion and Long-Term Treatment Plan

Isabella experienced significant improvements in mood, sleep, and overall well-being with a comprehensive integrative medicine approach. Her case highlights the effectiveness of addressing hormonal balance, neurotransmitter function, and lifestyle modifications for adolescent mental health.

Next Steps:

  1. Continue supporting sleep and stress resilience
  2. Maintain hormonal balance with ongoing monitoring
  3. Encourage emotional and academic balance

Ready to learn more about nutritional and functional medicine for teen and adolescent mental illness? Check out our new Certified Pediatric Fellowship in Functional Psychiatry led by James Greenblatt, MD. Book a private call now to learn more and inquire about scholarships!

Book a 1:1 Call Now

References

  • Birdsall, T. C. (1998). “5-Hydroxytryptophan: a clinically-effective serotonin precursor.” Alternative Medicine Review, 3(4), 271-280.
  • Boyle, N. B., Lawton, C., & Dye, L. (2017). “The effects of magnesium supplementation on subjective anxiety and stress.” Nutrients, 9(5), 429.
  • Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). “A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults.” Indian Journal of Psychological Medicine, 34(3), 255-262.
  • Ferracioli-Oda, E., Qawasmi, A., & Bloch, M. H. (2013). “Meta-analysis: melatonin for the treatment of primary sleep disorders.” PLoS One, 8(5), e63773.
  • Holick, M. F. (2011). “Vitamin D: evolutionary, physiological and health perspectives.” Current Drug Targets, 12(1), 4-18.
  • Lopresti, A. L., Hood, S. D., & Drummond, P. D. (2014). “A review of curcumin’s antidepressant effects: a new mechanism of action?” Journal of Affective Disorders, 167, 368-377.
  • Neri, D. F., Wiegmann, D., Stanny, R. R., Shappell, S. A., McCardie, A., & McKay, D. L. (1995). “The effects of tyrosine on cognitive performance.” Aviation, Space, and Environmental Medicine, 66(4), 313-318.
  • Papakostas, G. I. (2010). “S-Adenosyl Methionine (SAMe) for the treatment of major depressive disorder.” Journal of Clinical Psychiatry, 71(6), 669-677.
  • Talbott, S. M., Talbott, J. A., George, A., & Pugh, M. (2013). “Effect of Magnolia and Phellodendron bark extract on cortisol and mood states in moderately stressed subjects.” Journal of the International Society of Sports Nutrition, 10(Suppl 1), P37.
  • Unfer, V., Facchinetti, F., Orrù, B., Giordani, B., & Nestler, J. E. (2017). “Inositols: from physiology to therapeutic applications.” Expert Opinion on Drug Metabolism & Toxicology, 13(10), 1033-1046.